Many R&D firms are moving from traditional lab spaces to premises that offer sufficient power and network capabilities.
Demand is expected to return soon to the 'big three' – Boston, San Francisco and San Diego.
High supply means life sciences tenants can call the shots, so meeting evolving user needs is paramount for investors.
In 2024, market vacancies increased with new construction delivered vacant, but this trend should reverse as demand and supply return to more manageable levels.
Driven primarily by a few large funds, capital accumulation in the proptech space has risen again despite difficult circumstances.
Venture capital funding is rebounding, which is driving rental growth.
The sector holds huge potential for transforming the real estate industry, but some firms are finding that implementing it is not always straightforward.
Year-on-year sales volume for lab, R&D space has continued to fall, but a turnaround is expected.
Enthusiastic fundraising for proptech belies adoption headaches, especially on AI.
In this podcast episode, three of this year’s Women of Influence in Private Markets who have built businesses from the ground up discuss how they found their niche.